Radioactive waste advisers training course

Course dates

29 September – 1 October 2025

Venue

The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, UK.

Waste adviser wearing protective uniform surveying barrels of radioactive waste

Credit: AP Photo/Lee Jin-man

This course is organised by the Joint Department of Physics of The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London.

Course outline

This course provides the theoretical background and training necessary for the management of unsealed and sealed radioactive substances in hospitals.

The first day covers the following subject areas: interaction and units, instrumentation, radiation effects and risks and the regulatory framework. The following two days cover the legislation, applying for a Permit and compliance with the Permit conditions, the transport regulations and practical management of radioactive substances in hospitals. As well as lectures, there will be workshop sessions covering some practical issues. The course centres on UK (English) Legislation. 

The course is at a level suitable for hospital physicists working in the field of radiation protection or those who want to expand their knowledge in this field. It is particularly suitable for those wishing to become Radioactive Waste Advisers (RWA), and covers the Basic Underpinning Knowledge (Basic Syllabus) as set out in the RPA2000 Guidance.

This is a CPD course approved by IPEM.  

Those wishing to use the course towards RWA certification can sit an optional marked short exam.

Provisional Lecture List

Day 1: Review and effects of radiation

  • Interactions and units
  • Instrumentation
  • Sources of exposures
  • Risks and effects
  • Radiation protection framework
  • Other legislation

Day 2: Statutory requirements

  • EPR2016
  • Permit compliance / BAT
  • Transport Regulations
  • Applying for an environmental permit
  • IRAT2
  • Cradle to grave: records management

Day 3: Radioactive source management in hospitals

  • HASS and other sealed sources
  • Security
  • RWA certification
  • RWA Portfolio Assessment
  • Optional assessment

Workshops

  • EPR audits
  • Incidents

The organisers may need to alter the final programme to fulfil practical commitments.

Course fees

 Full three days including first day review: Two-day module excluding 1st day review (for those who have already attended RPTC in past 5 years) 
Payments received on or before 1 August 2025 £450£315
Payments received after 1 August 2025

 £525

£420

The cost includes lunches and light refreshments. Lecture notes and a certificate of attendance are provided.

Registration

Online Registration Form

Downloadable Registration Form

You will be allocated a place on receipt of a completed registration form and purchase order or completed online payment. We are unable to accept provisional bookings.

The number of participants is limited, so early booking is advised.  Applications from outside the UK are welcome.

Closing date for registrations: Friday 5 September 2025

Related documents

2 Day Course - Provisional Timetable 2025

3 Day Course - Provisional Timetable 2025

Sutton Site Map

Contacts

Course organiser: Dr Allison Craig 

For registration details and any other queries contact:

Course administrator: Mrs Jessica Keegan.

 

Latest ICR News

How advances in microscopy are transforming structural biology at the ICR

07/08/25 - Robbie Lockyer

At The Institute of Cancer Research, London, our ability to visualise the intricate inner workings of cancer is going from strength to strength. Robbie Lockyer spoke with scientists using cutting-edge imaging techniques to uncover how these tools are helping us understand cancer in unprecedented detail.
See full story
Dame Stella Rimington
Dame Stella Rimington, former Chair of the ICR, dies aged 90

06/08/25

Dame Stella Rimington, who served as Chair of the Board of Trustees at The Institute of Cancer Research, London, from 1997 to 2005, died on 3 August 2025.
See full story
A picture of an MRI scanner
New MRI scan can spot tiny traces of blood cancer after treatment

04/08/25

Whole-body MRI scans provide powerful insights into treatment effectiveness and long-term outcomes for patients with myeloma, an incurable but treatable blood cancer.  Results from the iTIMM study led by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London have shown that whole-body MRI scans (WB-MRI) can detect tiny traces of the disease, known as minimal residual disease (MRD), in the bone marrow after treatment. This can provide a crucial insight into how well patients with multiple myeloma are responding to treatment and whether they might relapse - offering a potential new standard in how this complex blood cancer is assessed. 
See full story
Small fragments, big impact: discovering the 'shearosomes' that drive cancer's spread

30/07/25

A collaborative study reveals an unexpected way cancer spreads through the body – by shedding tiny, previously unidentified fragments called shearosomes as tumour cells squeeze through narrow blood vessels. Shearosomes appear to actively influence their surroundings, supporting the growth of secondary tumours, offering new insights into how cancer spreads.
See full story